Injectable Drug Delivery Market Dynamic Demand, Growth, Strategies and Forecast 2032

The global injectable drug delivery market size was valued at USD 561.0 billion in 2021 and is projected to reach up to 1,223.0 million in 2030, with a CAGR of 9.0% in the forecasted period.

The rising prevalence of cancer, increasing incidences of chronic diseases are driving the market growth. Moreover, the rise in biologics market is also among the prominent factors for the market growth in the forecasted period.

One of the substantial factors driving the growth of global injectable drug delivery market is rising prevalence of cancer. As per the International Agency for Research on Cancer, 1 in 5 individuals will develop cancer during their lifetime by December 2020, with 1 in 8 men and 1 in 11 women dying from the disease globally. According to the International Agency for Research, cancer cases and deaths will grow up to 19.3 million cases and 10 million deaths in 2020, up from 18 million cases and deaths in 2018. Moreover, the major market players are concentrating on new product development and launches. For instance, the U.S. Food and Drug Administration approved Apretude for pre-exposure prophylaxis to lower the risk of sexually acquired HIV in adults weighing at least 35 kg in December 2021.  

The COVID-19 pandemic has both valuable and negative impacts on the healthcare sector. The escalating COVID-19 patient populace is placing strain on healthcare systems. Due to the improved demand for medical things such as injections and pre-filled syringes, manufacturers have enhanced their making capacity to keep up with demand. Additionally, the government around the globe is backing towards the growth of injectable drugs delivery market. The government is profoundly investing for the growth and launch of novel injectable drugs delivery in the market.

Key Companies Insights
Key players are aiming on their technological partnerships, collaborations, and merger & acquisitions strategies to gain an economical edge and grow their product portfolio & business footmarks. The Covid-19 pandemic hindered the healthcare systems worldwide and driven the market players to transform products for unexploited opportunities. 

Fill Out Details to Receive FREE Sample Report Copy Here:

https://analyticsmarketresearch.com/sample-request/injectable-drug-delivery-market/21645/

Some of the key players operating in the global injectable drug delivery market include:
• BD
• Pfizer Inc.
• Teva Pharmaceuticals Industries Ltd.
• Eli Lilly and Company
• Baxter International, Inc.
• Sandoz
• Terumo
• Schott AG
• Gerresheimer
• Ypsomed
• Bespak
• B. Braun Melsungen
• Other players

Some of the Recent Developments:
• In 2016, Biocon launched its disposable pen product in Japan, which will be distributed by its partner Fujifilm Pharma throughout the country.
• In March 2015, BD bought CareFusion Corporation to expand its capabilities and improve drug management and patient safety. In the same year, BD purchased CRISI Medical Systems, a medical technology business, in order to improve the efficiency of drug delivery via IV injectable. BD has a worldwide presence in 50 nations, allowing it to maintain its position in the global market.
• In June 2020, Pfenex Inc. announced that Alvogen, its commercialization partner, had launched Teriparatide Injection in the U.S. for a variety of indications, including postmenopausal women with osteoporosis who are at high risk of broken bones.
• In 2014, Terumo Corporation partnered with Ypsomed Group. The organization combined their prefillable polymer syringe, PLAJEX, with YpsoMate as a result of this agreement. This aided the corporation in strengthening their syringe product offerings.
• In 2015, Sanford-Burnham Medical Research Institute and Eli Lilly and Company formed a partnership to discover immunological therapeutics for inflammatory bowel disorder, lupus, and autoimmune diseases. The expertise of both institutions will be pooled to discover novel treatments for these disorders.

Segments 
By Type
• Devices
o Conventional Injectables
o Pre-Filled Syringes
o Auto-Injectors
o Pen-Injectors
• Formulations

By Formulation Packaging
• Ampules
• Vials
• Cartridges
• Bottles

By Therapeutic Application
• Auto-immune diseases
• Hormonal Disorders
• Orphan Diseases
• Oncology
• Others

By Usage Pattern
• Curative Care
• Immunization
• Other

By Site of Administration
• Skin
• Circulatory/Musculoskeletal
• Organs
• Central Nervous System

By Distribution Channel
• Hospitals & Clinics
• Retail Pharmacy Stores
• Others

By Facility of Use
• Hospitals & Clinics
• Home Care Settings
• Other

By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt

For more information about this report visit:-

https://analyticsmarketresearch.com/reports/injectable-drug-delivery-market/21645/

Frequently Asked Questions
•  What is the market size and growth projections?
•  What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
•  What are the top performing segments, and countries / regions of each of the markets?
•  What is the market size and growth rate across key countries / regions?
•  How big is the global & regional market in terms of revenue and volume?
•  How far market will grow in forecast period in terms of revenue and volume?
•  What factors will influence demand and supply trends across each markets during the forecast period?
•  What are the technology trends shaping various markets?
•  Which country / region has more opportunities?
•  What is the COVID-19 impact on the market and how long will it take to recover?
•  Who are the key competitors of market Players?
•  What are the market share (%) of Key Players?
•  What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
•  What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?